|
Name |
3-[(3R,6R,7R)-6-(2,4-dihydroxy-6-methylbenzoyl)oxy-3,7-dihydroxy-7-methyl-8-oxo-1,4,5,6-tetrahydroisochromen-3-yl]propanoic acid
|
| Molecular Formula | C21H24O10 | |
| IUPAC Name* |
3-[(3R,6R,7R)-6-(2,4-dihydroxy-6-methylbenzoyl)oxy-3,7-dihydroxy-7-methyl-8-oxo-1,4,5,6-tetrahydroisochromen-3-yl]propanoic acid
|
|
| SMILES |
CC1=CC(=CC(=C1C(=O)O[C@@H]2CC3=C(CO[C@@](C3)(CCC(=O)O)O)C(=O)[C@]2(C)O)O)O
|
|
| InChI |
InChI=1S/C21H24O10/c1-10-5-12(22)7-14(23)17(10)19(27)31-15-6-11-8-21(29,4-3-16(24)25)30-9-13(11)18(26)20(15,2)28/h5,7,15,22-23,28-29H,3-4,6,8-9H2,1-2H3,(H,24,25)/t15-,20-,21-/m1/s1
|
|
| InChIKey |
UGUYPVZDRVCYAD-IPHXSNPTSA-N
|
|
| Synonyms |
Montagnuphilone C; CHEMBL4062763; J3.616.323B
|
|
| CAS | NA | |
| PubChem CID | 132992079 | |
| ChEMBL ID | CHEMBL4062763 |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 436.4 | ALogp: | 0.4 |
| HBD: | 5 | HBA: | 10 |
| Rotatable Bonds: | 6 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 171.0 | Aromatic Rings: | 3 |
| Heavy Atoms: | 31 | QED Weighted: | 0.424 |
| Caco-2 Permeability: | -5.969 | MDCK Permeability: | 0.00001240 |
| Pgp-inhibitor: | 0.002 | Pgp-substrate: | 0.996 |
| Human Intestinal Absorption (HIA): | 0.931 | 20% Bioavailability (F20%): | 1 |
| 30% Bioavailability (F30%): | 0.991 |
| Blood-Brain-Barrier Penetration (BBB): | 0.051 | Plasma Protein Binding (PPB): | 87.68% |
| Volume Distribution (VD): | 0.41 | Fu: | 14.89% |
| CYP1A2-inhibitor: | 0.053 | CYP1A2-substrate: | 0.1 |
| CYP2C19-inhibitor: | 0.024 | CYP2C19-substrate: | 0.049 |
| CYP2C9-inhibitor: | 0.027 | CYP2C9-substrate: | 0.804 |
| CYP2D6-inhibitor: | 0.01 | CYP2D6-substrate: | 0.115 |
| CYP3A4-inhibitor: | 0.164 | CYP3A4-substrate: | 0.077 |
| Clearance (CL): | 6.517 | Half-life (T1/2): | 0.876 |
| hERG Blockers: | 0.005 | Human Hepatotoxicity (H-HT): | 0.066 |
| Drug-inuced Liver Injury (DILI): | 0.959 | AMES Toxicity: | 0.049 |
| Rat Oral Acute Toxicity: | 0.351 | Maximum Recommended Daily Dose: | 0.033 |
| Skin Sensitization: | 0.037 | Carcinogencity: | 0.756 |
| Eye Corrosion: | 0.003 | Eye Irritation: | 0.028 |
| Respiratory Toxicity: | 0.505 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC003838 | ![]() |
1.000 | D08NQZ | ![]() |
0.256 | ||
| ENC003839 | ![]() |
1.000 | D0R6RC | ![]() |
0.252 | ||
| ENC003451 | ![]() |
0.822 | D02GAC | ![]() |
0.250 | ||
| ENC003450 | ![]() |
0.822 | D05AFR | ![]() |
0.248 | ||
| ENC005503 | ![]() |
0.590 | D04VEJ | ![]() |
0.245 | ||
| ENC003837 | ![]() |
0.577 | D0J2NK | ![]() |
0.243 | ||
| ENC002211 | ![]() |
0.543 | D07MGA | ![]() |
0.241 | ||
| ENC002132 | ![]() |
0.532 | D0WY9N | ![]() |
0.230 | ||
| ENC002726 | ![]() |
0.529 | D03CEF | ![]() |
0.227 | ||
| ENC003448 | ![]() |
0.500 | D08LTU | ![]() |
0.223 | ||